本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BLACKROCK HEALTH SCIENCES TERM TRST

14.60
-0.3000-2.01%
盘前14.50-0.1000-0.68%09:23 EDT
成交量:54.94万
成交额:808.28万
市值:14.78亿
市盈率:-1.50
高:14.89
开:14.80
低:14.58
收:14.90
数据加载中...
2024/10/11

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/05/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/14

SEC问询函

Form CORRESP - Correspondence
2024/04/26

SEC问询函

Form CORRESP - Correspondence
2024/03/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/31

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/04

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/28

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/04

SEC问询函

Form CORRESP - Correspondence
2023/05/26

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2021/08/09

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/06/21

持股变动声明

3 - Initial statement of beneficial ownership of securities